Medigen Biotechnology Corp. (TPEX: 3176)

Medigen Biotechnology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1,873	2,223	2,041	2,145	2,207	813.69
Short-Term Investments	729.05	2,364	3,040	800	-	25.21
Trading Asset Securities	-	0.49	54.23	53.6	54.2	77.22
Cash & Short-Term Investments	2,602	4,588	5,135	2,998	2,261	916.11
Cash Growth	-44.02%	-10.67%	71.28%	32.62%	146.78%	-20.02%
Accounts Receivable	346.66	328.89	398.31	800.22	151.21	151.25
Other Receivables	90.66	124.72	66.37	35.46	130.51	3.35
Receivables	437.31	453.61	464.69	835.68	281.72	154.6
Inventory	639.47	546.91	692.62	752.87	323.29	135.27
Prepaid Expenses	23.97	33.61	382.35	99.59	-	-
Other Current Assets	33.97	86.4	57.93	231.96	155.9	106.15
Total Current Assets	3,736	5,708	6,733	4,918	3,022	1,312
Property, Plant & Equipment	1,985	2,043	2,198	2,189	2,166	2,540
Long-Term Investments	601.08	292.87	307.33	363.71	156.49	222.47
Goodwill	76.18	76.18	76.18	76.18	76.18	76.18
Other Intangible Assets	27.46	30.36	36.9	48.08	79.34	105.3
Long-Term Deferred Tax Assets	326.47	327.5	480.94	522.18	555.68	519.2
Other Long-Term Assets	38.97	49.1	150.42	81.75	97.02	53.26
Total Assets	6,791	8,527	9,982	8,199	6,152	4,829
Accounts Payable	109.74	122.57	185.01	163.94	110	107.72
Short-Term Debt	315.9	402.6	328	300	475	375
Current Portion of Long-Term Debt	40.03	1,728	28.86	21.34	21.39	110.89
Current Portion of Leases	17.94	17.32	13.13	3.32	3.02	11.46
Current Income Taxes Payable	16.11	24.63	22.99	-	-	-
Current Unearned Revenue	225.99	135	130.4	244.42	113.92	101.89
Other Current Liabilities	313.41	349.37	343.94	331.89	210.47	223.5
Total Current Liabilities	1,039	2,780	1,052	1,065	933.8	930.46
Long-Term Debt	369.14	449.1	2,129	470.77	486.37	846.01
Long-Term Leases	261.78	267.53	275.32	196.64	195.67	333.46
Long-Term Unearned Revenue	-	-	-	-	-	0.26
Long-Term Deferred Tax Liabilities	14.27	14.15	14.24	14.35	18.15	21.99
Other Long-Term Liabilities	10.28	10.28	29.53	15.89	7.62	2.13
Total Liabilities	1,702	3,530	3,511	1,773	1,653	2,144
Common Stock	1,392	1,393	1,394	1,394	1,390	1,390
Additional Paid-In Capital	491.52	968.14	1,562	1,109	1,101	298.22
Retained Earnings	-213.3	-747.51	-727.98	-52.82	-631.38	-300.99
Comprensive Income & Other	4.27	-22.45	-34.12	-54.96	-44.37	-25.97
Total Common Equity	1,675	1,592	2,194	2,394	1,815	1,361
Minority Interest	3,414	3,405	4,277	4,032	2,684	1,324
Shareholders' Equity	5,089	4,997	6,471	6,426	4,499	2,685
Total Liabilities & Equity	6,791	8,527	9,982	8,199	6,152	4,829
Total Debt	1,005	2,865	2,774	992.07	1,181	1,677
Net Cash (Debt)	1,597	1,723	2,361	2,006	1,079	-760.71
Net Cash Growth	-11.00%	-27.03%	17.68%	85.87%	-	-
Net Cash Per Share	11.46	12.36	16.97	14.44	7.77	-5.49
Filing Date Shares Outstanding	139.23	139.35	139.45	139.36	138.99	138.99
Total Common Shares Outstanding	139.23	139.35	139.45	139.36	138.99	138.99
Working Capital	2,697	2,928	5,681	3,853	2,088	381.67
Book Value Per Share	12.03	11.42	15.73	17.18	13.06	9.79
Tangible Book Value	1,571	1,485	2,081	2,270	1,660	1,180
Tangible Book Value Per Share	11.28	10.66	14.92	16.29	11.94	8.49
Land	330.29	330.29	354.04	354.04	354.04	354.04
Buildings	1,467	1,465	1,506	1,500	1,495	1,494
Machinery	1,236	1,266	1,240	1,178	1,002	970.83
Construction In Progress	2.64	21.37	14.54	4.7	17.9	119.35
Leasehold Improvements	3.27	3.34	3.03	2.55	1.89	1.89

Source: S&P Capital IQ. Standard template. Financial Sources.